Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron augmentation in treatment-resistant OCD
NCT00796497Phase 4Completed
- Sponsor
- Institute of Neuroscience, Florence
- Start
- Mar 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ondansetron in obsessive compulsive disorder (OCD), sponsored by Institute of Neuroscience, Florence. Started Mar 2008; status: completed.
02
Drugs
ondansetron
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00796497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796497.